NCT01162018

Brief Summary

The proposed study will recruit 60 women with breast cancer who finished undergoing treatment who complain of persistent insomnia problems that began with onset of their cancer diagnosis. The eligible women would be randomized and stratified by sleep problems to two arms: (Acupuncture Arm vs. Sham Acupuncture) with a goal of having 48 patients complete the study (we anticipate about 20% attrition rate). The study interventions will begin after patients completed their treatment. The placebo control for acupuncture will be a validated sham acupuncture control Assessments will be made with daily diaries and with weekly questionnaires. PSG data will be collected on the subsample of the population. Data will be gathered via pencil-and-paper measures before, during, immediately following, one month following the completion of treatment and six months after the conclusion of treatment. In addition, actigraphy data (objective sleep continuity data) will be acquired prior to and following treatment

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
65

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2011

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 2, 2010

Completed
12 days until next milestone

First Posted

Study publicly available on registry

July 14, 2010

Completed
7 months until next milestone

Study Start

First participant enrolled

February 1, 2011

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2012

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2012

Completed
Last Updated

April 4, 2019

Status Verified

April 1, 2019

Enrollment Period

1.4 years

First QC Date

July 2, 2010

Last Update Submit

April 2, 2019

Conditions

Outcome Measures

Primary Outcomes (3)

  • Fatigue reduction

    1 month and 3 months post final acupuncture treatment

  • Quality of life in breast cancer survivors after acupuncture

    Quality of life in breast cancer survivors after acupuncture will be measured through questionnaire using 28 item scale of functional assessment of chronic illness therapy- fatigue subscale (FACIT-F) version 4. Total score ranges from 0 to 108. A higher score indicates better quality of life.

    1 month and 6 months post final acupuncture treatment

  • Insomnia reduction

    1 month and 3 months post final acupuncture treatment

Study Arms (2)

Acupuncture Arm

EXPERIMENTAL
Procedure: acupuncture

Sham Acupuncture

SHAM COMPARATOR

Sham Acupuncture

Other: placebo

Interventions

acupuncturePROCEDURE

The eligible women would be randomized and stratified by sleep problems to two arms: (Acupuncture Arm vs. Sham Acupuncture) with a goal of having 48 patients complete the study (we anticipate about 20% attrition rate). The study interventions will begin after patients completed their treatment. The placebo control for acupuncture will be a validated sham acupuncture control Assessments will be made with daily diaries and with weekly questionnaires. There are ten sessions each lasting approximately 20 minutes. All participants will have PSG data collected.

Acupuncture Arm
placeboOTHER
Sham Acupuncture

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Females diagnosed with breast cancer who are not currently undergoing cancer treatment (hormonal treatment is permitted).
  • The last cancer treatment ≥ 2 weeks prior to screening.
  • ≥ 21 years of age.
  • Able to understand written and spoken English.
  • Have a habitual bedtime between 9:00 pm and 3:00 am and a habitual rise time between 4:00 am and 11 am.
  • Meet DSM-IV criteria for insomnia (determined by the of the Duke Structured Interview of Sleep Disorders) with duration ≥ 1 month by Screening.
  • Willingness to discontinue the use of any current sleep aides (prescription, OTC, or naturopathic agents).
  • Properly executed Informed Consent.
  • Karnofsky Performance Scale Index score ≥ to 70, (patients who score between 61-69 might be included per PI's evaluation).
  • Insomnia Severity Index (ISI) \> 8 at Screening.
  • Able to travel to Stanford University and vicinity for assessments and acupuncture treatments.

You may not qualify if:

  • Unstable medical or psychiatric illness (eMINI, current or within the last 5 years).
  • Exposure to acupuncture within 6 months prior to screening.
  • Currently pregnant or nursing.
  • History of substance abuse or meet criteria for current alcohol abuse or dependence.
  • Center for Epidemiological Studies Depression Scale (CES-D) \>27 at Screening. Meet criteria for sleep apnea, restless legs syndrome or Circadian Rhythm Sleep Disorder on the basis of the Duke Structured Interview of Sleep Disorders (DSISD) or STOP-BANG is ≥ to 3.
  • Major surgery within 4 weeks prior to first acupuncture treatment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Stanford University School of Medicine

Stanford, California, 94305, United States

Location

MeSH Terms

Conditions

Sleep Initiation and Maintenance DisordersBreast Neoplasms

Interventions

Acupuncture Therapy

Condition Hierarchy (Ancestors)

Sleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental DisordersNeoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeutics

Study Officials

  • David Spiegel

    Stanford University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Jack, Samuel and Lulu Willson Professor in Medicine

Study Record Dates

First Submitted

July 2, 2010

First Posted

July 14, 2010

Study Start

February 1, 2011

Primary Completion

July 1, 2012

Study Completion

August 1, 2012

Last Updated

April 4, 2019

Record last verified: 2019-04

Locations